AIMS/HYPOTHESIS: Virally induced inflammatory responses, beta cell destruction and release of beta cell autoantigens may lead to autoimmune reactions culminating in type 1 diabetes. Therefore, viral capability to induce beta cell death and the nature of virus-induced immune responses are among key determinants of diabetogenic viruses. We hypothesised that enterovirus infection induces a specific gene expression pattern that results in islet destruction and that such a host response pattern is not shared among all enterovirus infections but varies between virus strains. METHODS: The changes in global gene expression and secreted cytokine profiles induced by lytic or benign enterovirus infections were studied in primary human pancreatic islet using DNA microarrays and viral strains either isolated at the clinical onset of type 1 diabetes or capable of causing a diabetes-like condition in mice. RESULTS: The expression of pro-inflammatory cytokine genes (IL-1-α, IL-1-β and TNF-α) that also mediate cytokine-induced beta cell dysfunction correlated with the lytic potential of a virus. Temporally increasing gene expression levels of double-stranded RNA recognition receptors, antiviral molecules, cytokines and chemokines were detected for all studied virus strains. Lytic coxsackievirus B5 (CBV-5)-DS infection also downregulated genes involved in glycolysis and insulin secretion. CONCLUSIONS/ INTERPRETATION: The results suggest a distinct, virus-strain-specific, gene expression pattern leading to pancreatic islet destruction and pro-inflammatory effects after enterovirus infection. However, neither viral replication nor cytotoxic cytokine production alone are sufficient to induce necrotic cell death. More likely the combined effect of these and possibly cellular energy depletion lie behind the enterovirus-induced necrosis of islets.
AIMS/HYPOTHESIS: Virally induced inflammatory responses, beta cell destruction and release of beta cell autoantigens may lead to autoimmune reactions culminating in type 1 diabetes. Therefore, viral capability to induce beta cell death and the nature of virus-induced immune responses are among key determinants of diabetogenic viruses. We hypothesised that enterovirus infection induces a specific gene expression pattern that results in islet destruction and that such a host response pattern is not shared among all enterovirus infections but varies between virus strains. METHODS: The changes in global gene expression and secreted cytokine profiles induced by lytic or benign enterovirus infections were studied in primary humanpancreatic islet using DNA microarrays and viral strains either isolated at the clinical onset of type 1 diabetes or capable of causing a diabetes-like condition in mice. RESULTS: The expression of pro-inflammatory cytokine genes (IL-1-α, IL-1-β and TNF-α) that also mediate cytokine-induced beta cell dysfunction correlated with the lytic potential of a virus. Temporally increasing gene expression levels of double-stranded RNA recognition receptors, antiviral molecules, cytokines and chemokines were detected for all studied virus strains. Lytic coxsackievirus B5 (CBV-5)-DS infection also downregulated genes involved in glycolysis and insulin secretion. CONCLUSIONS/ INTERPRETATION: The results suggest a distinct, virus-strain-specific, gene expression pattern leading to pancreatic islet destruction and pro-inflammatory effects after enterovirus infection. However, neither viral replication nor cytotoxic cytokine production alone are sufficient to induce necrotic cell death. More likely the combined effect of these and possibly cellular energy depletion lie behind the enterovirus-induced necrosis of islets.
Authors: P Ylipaasto; B Kutlu; S Rasilainen; J Rasschaert; K Salmela; H Teerijoki; O Korsgren; R Lahesmaa; T Hovi; D L Eizirik; T Otonkoski; M Roivainen Journal: Diabetologia Date: 2005-07-01 Impact factor: 10.122
Authors: P A Hyslop; D B Hinshaw; W A Halsey; I U Schraufstätter; R D Sauerheber; R G Spragg; J H Jackson; C G Cochrane Journal: J Biol Chem Date: 1988-02-05 Impact factor: 5.157
Authors: Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov Journal: Proc Natl Acad Sci U S A Date: 2005-09-30 Impact factor: 11.205
Authors: Barbara M Schulte; Matthijs Kramer; Marleen Ansems; Kjerstin H W Lanke; Neeltje van Doremalen; Jon D Piganelli; Rita Bottino; Massimo Trucco; Jochem M D Galama; Gosse J Adema; Frank J M van Kuppeveld Journal: Diabetes Date: 2010-01-13 Impact factor: 9.461
Authors: Susan J Burke; Michael D Karlstad; Kellie M Regal; Tim E Sparer; Danhong Lu; Carrie M Elks; Ryan W Grant; Jacqueline M Stephens; David H Burk; J Jason Collier Journal: Biochim Biophys Acta Date: 2015-04-13
Authors: Benjamin M Looney; Chang-Qing Xia; Patrick Concannon; David A Ostrov; Michael J Clare-Salzler Journal: Curr Diab Rep Date: 2015-11 Impact factor: 4.810
Authors: Avishag Abecassis; Ronen Schuster; Galit Shahaf; Eyal Ozeri; Ross Green; David E Ochayon; Peleg Rider; Eli C Lewis Journal: Cell Mol Immunol Date: 2014-04-07 Impact factor: 11.530
Authors: Laura Marroqui; Miguel Lopes; Reinaldo S dos Santos; Fabio A Grieco; Merja Roivainen; Sarah J Richardson; Noel G Morgan; Anne Op de Beeck; Decio L Eizirik Journal: Elife Date: 2015-06-10 Impact factor: 8.140
Authors: Tineke C T M van der Pouw Kraan; Weena J Chen; Mathijs C M Bunck; Daniel H van Raalte; Nynke J van der Zijl; Renate E van Genugten; Liselotte van Bloemendaal; Josefien M Baggen; Erik H Serné; Michaela Diamant; Anton J G Horrevoets Journal: BMC Med Genomics Date: 2015-05-09 Impact factor: 3.063